Two recent case reports concerning intravitreal anti-VEGF use, one from Italy (Trifirò et al., 2018) and one from Germany (Meyer et al., 2018), identified a potential link with Parkinson’s disease and cognitive impairment, respectively. Here, VEGFA is linked to Cognitive impairment.